Bookmark jobad
Share jobad
We are an interdisciplinary Emmy Noether research group funded by the German Research Foundation (DFG). We combine epidemiological research, applied modelling, and health-economic evaluation to improve population health. Our project “OpTBtreat” investigates how interventions before, during, and after tuberculosis treatment can improve patients’ health outcomes. We combine evidence synthesis, modelling, and health-economic analysis to guide which interventions to develop and prioritise, for whom, and at what cost.
Our findings will help guide the development, prioritisation, and implementation of strategies to improve care in TB programmes.We are located at the Department of Infectious Disease and Tropical Medicine at Heidelberg University Hospital, combining clinical care with research on diagnostics, clinical interventions, and global health. We benefit from close links with the Heidelberg Institute for Global Health and collaborate with leading academic institutions, international research networks, WHO, and industry partners.
Scientific questions
Dr. Florian Marx
E-Mail: florian.marx@uni-heidelberg.de
Application process
Pia Steimer
E-Mail: pia.steimer@med.uni-heidelberg.de
Please apply online and help generate evidence to improve global tuberculosis care.
Note: The UKHD is subject to the provisions of the Infektionsschutzgesetz. Therefore, a valid measles immunity certificate is required for all persons employed at the UKHD.
The UKHD embraces diversity and values diversity.
Regardless of age, gender, sexual identity, disability, origin or religion, we offer everyone the same opportunities. If one gender is underrepresented in a particular area, we place particular emphasis on counteracting this imbalance. If they have the same aptitude, qualifications and professional performance, we give priority to people with severe disabilities when considering them for vacancies.
Losberger De Boer Gruppe · Losberger GmbH